Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Disruptive innovation in healthcare requires disruptive innovation in medical ethics

Project description

Tailoring the medical ethics toolbox to an era of profound and rapid change

There are many recent medical innovations that do not conform with the way medicine traditionally operates, ultimately blurring the boundaries of medicine while also side-lining the doctor–patient relationship as an essential aspect of healthcare. Coping with these issues is critical. The EU-funded DIME project will investigate whether the discipline of medical ethics is sufficiently equipped to guide new, disruptive innovations towards their great potential for improving patients’ access to good quality healthcare, while also safeguarding patients/users against the risks that come with them. These risks could be health-related, as well as include infractions against firmly rooted values such as patient autonomy, the duty of care, confidentiality or privacy. Suggestions will be made regarding adaptations and reorientations in medical ethics to better cope with the emergence of disruptive innovations.

Objective

Several recent medical innovations do not conform with the way medicine traditionally operates, but rather blur the boundaries of medicine and/or side-line the doctor-patient relationship as an essential aspect of healthcare. Examples of this are healthcare apps, direct-to-consumer genetic testing, disease surveillance, electronic patient records, telehealth and certain types of clinical decision support systems. I postulate that several of these new innovations will fundamentally change the very concept of medicine and thus turn out to be disruptive innovations.

Given that medical ethics are tailored to ‘traditional’ medicine, we should be critical about its current ability to cope with these changes and question whether the discipline of medical ethics is sufficiently equipped to guide new, disruptive innovations in healthcare towards their great potential in terms of improving patients’ access to good quality healthcare, while also safeguarding patients/users for the risks that come with them, not only in terms of health, but also in terms of infractions against firmly rooted values such as patient autonomy, the duty of care, confidentiality or privacy. If the medical ethics toolbox is ill-equipped to deal with these challenges, we urgently need to rethink or replace procedures, principles or theories in order to remedy this problem.

DIME will address these challenges by focusing on three main objectives:
(1) To establish where the most prominent ethical disruptions are located and therefore in which areas re-orientations of ethical principles are most urgently needed.
(2) To develop normative arguments regarding which fundamental procedures, principles or theories in medical ethics ought to be reinforced, adapted or replaced in the face of disruptive innovations to better cope with the challenges ahead.
(3) To critically analyse the shifting moral responsibilities in healthcare as a consequence of disruptive innovations.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

ERC-STG - Starting Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2020-STG

See all projects funded under this call

Host institution

UNIVERSITEIT GENT
Net EU contribution
€ 1 273 750,00
Address
SINT PIETERSNIEUWSTRAAT 25
9000 Gent
Belgium
Region
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 273 750,00

Beneficiaries (1)